Selection of antisense oligodeoxynucleotides against glutathione S-transferase Mu

RNA

Volumn 8, Issue 12, 2002, Pages 1572-1583

  'T Hoen, Peter A C ^a   Out, Ruud ^a   Commandeur, Jan N M ^a   Vermeulen, Nico P E ^a   Batenburg, Van ^b   Manoharan, Muthiah ^c   Van Berkel, Theo J C ^a   Biessen, Erik A L ^a   Bijsterbosch, Martin K ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

^c ISIS PHARMACEUTICALS   (United States)

Author keywords

Carcinogenesis; Genetic polymorphism; In vitro translation; RNA accessible sites; RNA folding; RNase H

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; GLUTATHIONE S TRANSFERASE MU; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE M2; MESSENGER RNA; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENESIS; COMPUTER PROGRAM; ENZYME ANALYSIS; ENZYME DEFICIENCY; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA STRUCTURE; RNA TRANSLATION;

CELL-FREE SYSTEM; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; GLUTATHIONE TRANSFERASE; NUCLEIC ACID CONFORMATION; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; PROTEIN BIOSYNTHESIS; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; RIBONUCLEASE H, CALF THYMUS; RNA, MESSENGER; SOFTWARE; TRANSCRIPTION, GENETIC;

EID: 0036917846     PISSN: 13558382     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Abrahams JP, van den Berg M, van Batenburg E, Pleij C. 1990. Prediction of RNA secondary structure, including pseudoknotting, by computer simulation. Nucleic Acids Res 18:3035-3044.
2. Agrawal S. 1999. Importance of nucleotide sequence and chemical modifications of antisense oligonucleotides. Biochim Biophys Acta 1489:53-68.
3. Agrawal S, Jiang Z, Zhao Q, Shaw D, Cai Q, Roskey A, Channavajjala L, Saxinger C, Zhang R. 1997. Mixed-backbone oligonucleotides as second generation antisense oligonucleotides: In vitro and in vivo studies. Proc Natl Acad Sci USA 94:2620-2625.
4. Alt M, Renz R, Hofschneider PH, Caselmann WH. 1997. Core specific antisense phosphorothioate oligodeoxynucleotides as potent and specific inhibitors of hepatitis C viral translation. Arch Virol 142:589-599.
5. Bertrand JR, Rayner B, Imbach JL, Paoletti C, Malvy C. 1989. Comparative activity of alpha- and beta-anomeric oligonucleotides on rabbit beta globin synthesis: Inhibitory effect of cap targeted alpha-oligonucleotides. Biochem Biophys Res Commun 164:311-318.
6. Bijsterbosch MK, Rump ET, De Vrueh RL, Dorland R, van Veghel R, Tivel KL, Biessen EA, van Berkel TJ, Manoharan M. 2000. Modulation of plasma protein binding and in vivo liver cell uptake of phosphorothioate oligodeoxynucleotides by cholesterol conjugation. Nucleic Acids Res 28:2717-2725.
7. Brown DA, Kang SH, Gryaznov SM, DeDionisio L, Heidenreich O, Sullivan S, Xu X, Nerenberg MI. 1994. Effect of phosphorothioate modification of oligodeoxynucleotides on specific protein binding. J Biol Chem 269:26801-26805.
8. Cazenave C, Stein CA, Loreau N, Thuong NT, Neckers LM, Subasinghe C, Helene C, Cohen JS, Toulme JJ. 1989. Comparative inhibition of rabbit globin mRNA translation by modified antisense oligodeoxynucleotides. Nucleic Acids Res 17:4255-4273.
9. Chen T-Z, Lin S-B, Wu J-C, Choo K-B, Au L-C. 1996. A method for screening antisense oligodeoxyribonucleotides effective for mRNA translation-arrest. J Biochem 119:252-255.
10. Commandeur JNM, Stijntjes GJ, Vermeulen NPE. 1995. Enzymes and transport systems involved in the formation and disposition of glutathione S-conjugates. Role in bioactivation and detoxication mechanisms of xenobiotics. Pharmacol Rev 47:271-330.
11. Crooke ST, Bennett CF. 1996. Progress in antisense oligonucleotide therapeutics. Annu Rev Pharmacol Toxicol 36:107-129.
12. Dean NM, McKay R, Condon TP, Bennett CF. 1994. Inhibition of protein kinase C-alpha expression in human A549 cells by antisense oligonucleotides inhibits induction of intercellular adhesion molecule 1 (ICAM-1) mRNA by phorbol esters. J Biol Chem 269:16416-16424.
13. Ding Y, Lawrence CE. 2001. Statistical prediction of single-stranded regions in RNA secondary structure and application to predicting effective antisense target sites and beyond. Nucleic Acids Res 29:1034-1046.
14. Flanagan WM, Wagner RW. 1997. Potent and selective gene inhibition using antisense oligodeoxynucleotides. Mol Cell Biochem 172:213-225.
15. Gee JE, Robbins I, van der Laan AC, van Boom JH, Colombier C, Leng M, Raible AM, Nelson JS, Lebleu B. 1998. Assessment of high-affinity hybridization, RNase H cleavage, and covalent linkage in translation arrest by antisense oligonucleotides. Antisense Nucleic Acid Drug Dev 8:103-111.
16. Ghosh MK, Ghosh K, Cohen JS. 1992. Translation inhibition by phosphorothioate oligodeoxynucleotides in cell-free systems. Antisense Res Dev 2:111-118.
17. Gultyaev AP, Van Batenburg FHD, Pleij CWA. 1995. The computer simulation of RNA folding pathways using a genetic algorithm. J Mol Biol 250:37-51.
18. Ho SP, Bao Y, Lesher T, Malhotra R, Ma LY, Fluharty SJ, Sakai RR. 1998. Mapping of RNA accessible sites for antisense experiments with oligonucleotide libraries. Nat Biotechnol 16:59-63.
19. Jaroszewski JW, Syi JL, Ghosh M, Ghosh K, Cohen JS. 1993. Targeting of antisense DNA: Comparison of activity of anti-rabbit beta-globin oligodeoxyribonucleoside phosphorothioates with computer predictions of mRNA folding. Antisense Res Dev 3:339-348.
20. Kawajiri K, Watanabe J, Eguchi H, Hayashi S. 1995. Genetic polymorphisms of drug-metabolizing enzymes and lung cancer susceptibility. Pharmacogenetics 5:S70-73.
21. Keller C, Ali Osman F. 1998. Translational inhibition of messenger RNA of the human pi class glutathione S-transferase by antisense oligodeoxyribonucleotides. Chem Biol Interact 112:307-323.
22. Lefebvre d'Hellencourt C, Diaw L, Cornillet P, Guenounou M. 1996. Inhibition of human TNF alpha and LT in cell-free extracts and in cell culture by antisense oligonucleotides. Biochim Biophys Acta 1317:168-174.
23. Lima WF, Monia BP, Ecker DJ, Freier SM. 1992. Implication of RNA structure on antisense oligonucleotide hybridization kinetics. Biochemistry 31:12055-12061.
24. McWilliams JE, Sanderson BJ, Harris EL, Richert-Boe KE, Henner WD. 1995. Glutathione S-transferase M1 (GSTM1) deficiency and lung cancer risk. Cancer Epidemiol Biomarkers Prev 4:589-594.
25. Milner N, Mir KU, Southern EM. 1997. Selecting effective antisense reagents on combinatorial oligonucleotide arrays. Nat Biotechnol 15:537-541.
26. Monia BP, Johnston JF, Geiger T, Muller M, Fabbro D. 1996. Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase. Nat Med 2:668-675.
27. Pan WH, Devlin HF, Kelley C, Isom HC, Clawson GA. 2001. A selection system for identifying accessible sites in target RNAs. RNA 7:610-621.
28. Patzel V, Steidl U, Kronenwett R, Haas R, Sczakiel G. 1999. A theoretical approach to select effective antisense oligodeoxyribonucleotides at high statistical probability. Nucleic Acids Res 27:4328-4334.
29. Sczakiel G, Homann M, Rittner K. 1993. Computer-aided search for effective antisense RNA target sequences of the human immunodeficiency virus type 1. Antisense Res Dev 3:45-52.
30. Seidegard J, Vorachek WR, Pero RW, Pearson WR. 1988. Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion. Proc Natl Acad Sci USA 85:7293-7297.
31. Seki M, Honda Y. 1995. Phosphorothioate antisense oligodeoxynucleotides capable of inhibiting hepatitis C virus gene expression: In vitro translation assay. J Biochem (Tokyo) 118:1199-1204.
32. Sohail M, Akhtar S, Southern EM. 1999. The folding of large RNAs studied by hybridization to arrays of complementary oligonucleotides. RNA 5:646-655.
33. Sohail M, Hochegger H, Klotzbucher A, Guellec RL, Hunt T, Southern EM. 2001. Antisense oligonucleotides selected by hybridization to scanning arrays are effective reagents in vivo. Nucleic Acids Res 29:2041-2051.
34. Sohail M, Southern EM. 2000. Selecting optimal antisense reagents. Adv Drug Deliv Rev 44:23-34.
35. Van Batenburg FHD, Gultyaev AP, Pleij CWA. 1995. An APL-programmed genetic algorithm for the prediction of RNA secondary structure. J Theor Biol 174:269-280.
36. Vickers TA, Wyatt JR, Freier SM. 2000. Effects of RNA secondary structure on cellular antisense activity, Nucleic Acids Res 28: 1340-1347.
37. Vidalin O, Major ME, Rayner B, Imbach JL, Trepo C, Inchauspe G. 1996. In vitro inhibition of hepatitis C virus gene expression by chemically modified antisense oligodeoxynucleotides. Antimicrob Agents Chemother 40:2337-2344.
38. Walder RY, Walder JA. 1988. Role of RNase H in hybrid-arrested translation by antisense oligonucleotides. Proc Natl Acad Sci USA 85:5011-5015.
39. Walter AE, Turner DH, Kim J, Lyttle MH, Muller P, Mathews DH, Zuker M. 1994. Coaxial stacking of helixes enhances binding of oligoribonucleotides and improves predictions of RNA folding. Proc Natl Acad Sci USA 91:9218-9222.
40. Wormhoudt LW, Commandeur JNM, Vermeulen NPE. 1999. Genetic polymorphisms of human N-acetyltransferase, cytochrome P450, glutathione-S-transferase, and epoxide hydrolase enzymes: Relevance to xenobiotic metabolism and toxicity. Crit Rev Toxicol 29:59-124.
41. Wrzesinski J, Legiewicz M, Ciesiolka J. 2000. Mapping of accessible sites for oligonucleotide hybridization on hepatitis delta virus ribozymes. Nucleic Acids Res 28:1785-1793.
42. Zeng G. 1998. Sticky-end PCR: New method for subcloning. Biotechniques 25:206-208.
43. Zhong S, Wyllie AH, Barnes D, Wolf CR, Spurr NK. 1993. Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis 14: 1821-1824.
44. Zuker M, Mathews DH, Turner DH. 1999. Algorithms and thermodynamics for RNA secondary structure prediction: A practical guide, In: Barciszewski J, Clark BFC, eds. RNA Biochemistry and Biotechnology, Amsterdam: Kluwer Academic Publishers. pp 11-43.
45. Zuker M, Stiegler P. 1981. Optimal computer folding of large RNA sequences using thermodynamics and auxiliary information. Nucleic Acids Res 9:133-148.